Cerebral venous sinus thrombosis and thrombophilia presenting as pseudo-tumour syndrome following mild head injury

Journal of Clinical Neuroscience

Volumn 11, Issue 8, 2004, Pages 924-927

  Muthukumar, N ^a,b  

^a JJ Hospitals   (India)

^b Anna Nagar Madurai 625 020 India   (India)

Author keywords

antiphospholipid antibodies; cerebral venous sinus thrombosis; magnetic resonance venography; mild head injury; protein C deficiency; thrombophilia

Indexed keywords

ACETAZOLAMIDE; ANTICOAGULANT AGENT; MANNITOL; PHENINDIONE; PHENYTOIN; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; BRAIN PSEUDOTUMOR; BRAIN VEIN; CASE REPORT; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GLASGOW COMA SCALE; HEAD INJURY; HUMAN; LABORATORY TEST; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; THROMBOPHILIA; TRAFFIC ACCIDENT;

ADULT; BRAIN NEOPLASMS; CEREBRAL ANGIOGRAPHY; CRANIOCEREBRAL TRAUMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; SINUS THROMBOSIS, INTRACRANIAL; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOSIS;

EID: 7444270760     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2003.10.032     Document Type: Article

References (43)

1. M. Victor A.H. Hooper Principles of Neurology 2001 McGraw-Hill New York 910 911
2. B.J. Iskandar, and J.P. Kapp Nonseptic venous occlusive disease R.H. Wilkins S.S. Rengachary Neurosurgery 1996 McGraw-Hill New York 2177 2190
3. U. Meier, F. Gartner, W. Knopf, R. Klotzer, and O. Wolf The traumatic dural sinus injury - a clinical study Acta Neurochir. (Wien) 119 1992 91 93
4. A.W. Carrie, and F.A. Jaffe Thrombosis of the superior sagittal sinus caused by trauma without penetrating injury J. Neurosurg. 11 1954 173 182
5. M.E. Kinal Traumatic thrombosis of dural venous sinuses in closed head injuries J. Neurosurg. 27 1967 142 145
6. R.H. Thomas Hypercoagulability syndromes Arch. Inter. Med. 161 2001 2422 2439
7. J.S. Levine, W.D. Branch, and J. Rauch The antiphospholipid syndrome N. Engl. J. Med. 346 2002 752 763
8. D. Alarcon-Segovia, and J. Sanchez-Guerrero Primary antiphospholipid syndrome J. Rheumatol. 16 1989 482 488
9. R.A. Asherson, M.A. Khamasta, and J. Ordi-Ros The primary antiphospholipid syndrome: major clinical and serological features Medicine (Baltimore) 68 1989 366 374
10. J.L. Vianna, M.A. Khamashta, and J. Ordi-Ros Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients Am. J. Med. 96 1994 3 9
11. M.D. Lockshin Answers to the antiphospholipid-antibody syndrome? N Engl J Med. 332 1995 1025 1027
12. M. Petri Epidemiology of the antiphospholipid antibody syndrome J. Autoimmun. 15 2000 145 151
13. R. Christopher, D. Nagaraja, N.S. Dixit, and C.P. Narayanan Anticardiolipin antibodies: a study in cerebral venous thrombosis Acta Neurol. Scand. 99 1999 121 124
14. J.R. Carhuapoma, P. Mitsias, and S.R. Levine Cerebral venous thrombosis and anticardiolipin antibodies Stroke 28 1997 2363 2369
15. M.A. Deschiens, J. Conard, and M.H. Horellou Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis Stroke 27 1996 1724 1730
16. P.A. Silburn, P.A. Sandstrom, C. Staples, P. Mowat, and R.S. Boyle Deep cerebral venous thrombosis presenting as an encephalitic illness Postgrad. Med. J. 72 1996 355 368
17. R.T. Couper, and F.C. Maxwell Anticardiolipin and acquired protein S deficiency in early childhood J. Paediatr. Child Health 30 1994 363 365
18. B. Mokri, C.R. Jack Jr., and G.W. Petty Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies Stroke 24 1993 469 472
19. C.J. Fisher Jr., and B. Yan Protein C levels as a prognostic indicator of outcome in sepsis and related diseases Crit. Care Med. 28 S 2000 49 56
20. A. Gruber, E. Mori, and G.J. del Zoppo Alteration of fibrin network by activated protein C Blood 83 1994 2541 2548
21. D.J. Loskutoff, M. Sawdey, and J. Mimuro Type 1 plasminogen activator inhibitor Prog. Hemost. Thromb. 9 1989 87 115
22. V.W.M. van Hinsbergh, R.M. Bertina, and A. van Wijngaarden Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium Blood 65 1985 444 451
23. N.J. de Fouw, N.H. van Tilberug, and F. Haverkate Activated protein C accelerates clot lysis by virtue of its anticoagulant activity Blood Coagul. Fibrin. 4 1993 201 210
24. W. Marz, M. Nauck, and H. Wieland The molecular mechanisms of inherited thrombophilia Z. Kardiol. 89 2000 575 586
25. J.H. Griffin Clinical studies on protein C Semin Thromb. Hemost. 10 1984 162 166
26. N. Abramson, and S. Abramson Hypercoagulability: clinical assessment and treatment South Med. J. 94 2001 997 1001
27. M. Hellgren, P.J. Svensson, and B. Dahlback Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives Am. J. Obstet. Gynecol. 173 1995 210 213
28. A.M. Cumming, R.C. Tait, and S. Fildes Diagnosis of APC resistance during pregnancy Br. J. Haematol. 92 1996 1026 1029
29. O.I. Olivieri, S. Friso, and F. Manzato Resistance to activated protein C in healthy women taking oral contraceptives Br. J. Haemtol. 91 1995 465 470
30. B.P. Koelleman, P.H. Reitsma, and C.F. Allaart Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families Blood 84 1994 1031 1035
31. S.R. Poort, F.R. Rosendaal, and P.H. Reitsma A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
32. P.R. Ames, C. Tommasinon, and G. D'Andrea Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies - prevalence and significance Thromb. Haemostat 79 1998 46 49
33. H. Mandel, B. Brenner, and M. Berant Coexistence of hereditary homocysteinuria and factor V Leiden - effect on thrombosis N. Engl. J. Med. 334 1996 763 768
34. V. De Stefano, I. Martinelli, and M.P. Mannucci The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation N. Engl. J. Med. 341 1999 801 806
35. G. Palaretti, N. Leali, and S. Coccheri Bleeding complications of oral anticoagulation treatment; an inception-cohort, prospective collaborative study (ISCOAT) Lancet 348 1996 423 428
36. C. Kearon, M. Gent, and J. Hirsh A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism N. Engl. J. Med. 340 1999 901 907
37. J.D. Dousketis, C. Kearon, S. Bates, E.K. Duku, and J.S. Ginsberg Risk of fatal pulmonary embolism in patients with treated venous thromboembolism JAMA 279 1998 458 462
38. P.A. Kyrle, E. Minar, and M. Hirschl High plasma levels of Factor VIII and risk of recurrent venous thromboembolism N. Engl. J. Med. 343 2000 457 462
39. K. Chow, Y.P. Gobin, J. Saver, C. Kidwell, P. Dong, and F. Vinuela Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis Stroke 31 2000 1420 1425
40. M.F. Philips, L.J. Bagley, G.P. Sinson, E.C. Raps, S.L. Galetta, E.L. Zager, and R.W. Hurst Endovascular thrombolysis for symptomatic cerebral venous thrombosis J. Neurosurg. 90 1999 65 71
41. P.C. Gerszten, W.C. Welch, M.P. Spearman, C.A. Jungreis, and R.L. Redner Isolated deep cerebral venous thrombosis treated by direct endovascular thrombolysis Surg. Neurol. 48 1997 261 266
42. M.P. Spearman, C.A. Jungreis, J.J. Wehner, P.C. Gerszten, and W.C. Welch Endovascular thrombolysis in deep cerebral venous thrombosis AJNR Am. J. Neuroradiol. 18 1997 502 506
43. T.A. Kuether, O. O'Neill, G.M. Nesbit, and S.L. Barnwell Endovascular treatment of traumatic dural sinus thrombosis: case report Neurosurgery 42 1998 1163 1167